Will Herrington
willkidney.bsky.social
Kidney doctor and professor of clinical trials and epidemiology of kidney disease at CTSU, University of Oxford. EMPA-KIDNEY & EASi-KIDNEY CI. Needs to be large & randomized (or a bike!)
👤 Joined on 26 January 2025
167
Followers
296
Following
9
Total Posts
📜 Kullanıcı Geçmişi
- 26 Oca 2025, 17:50
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@willkidney.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
🔍New study finds major benefits of sodium-glucose co-transporter-2 (SGLT2) inhibitors treatment for chronic kidney disease (CKB) regardless of the type of CKB patient Leanr more ➡️ buff.ly/LXYWqgA
Show Post🎉Over 300 sites are now collaborating in the EASi-KIDNEY trial! 📉EASi-KIDNEY will investigate whether a novel treatment can help slow the progression of chronic kidney disease (CKD) ➡️ buff.ly/PXTVVeE
Show Post
Collider bias affects genome-wide association studies (GWAS) of disease progression phenotypes. @willkidney.bsky.social ney.bsky.social This study reports a method to reduce this bias. Find out more ⬇️ www.nature.com/articles/s41...
Show Post
‘Dad strikes’ in London and Edinburgh demand better paternity leave
Show Post
🌍 History made! For the first time, kidney care is on the global health agenda. #WHA78 adopted a landmark resolution recognizing kidney health in the fight against #NCDs. 👏 Thanks to Guatemala and the global kidney community for making this possible! #KidneyHealthMatters
Show Post